HomeADAP • NASDAQ
add
Adaptimmune Therapeutics PLC - ADR
Previous close
$0.98
Day range
$0.94 - $1.02
Year range
$0.42 - $2.05
Market cap
282.95M USD
Avg Volume
2.31M
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 5.68M | -88.07% |
Operating expense | 19.73M | 34.96% |
Net income | -48.50M | -4,781.76% |
Net profit margin | -854.23 | -39,284.86% |
Earnings per share | -0.03 | — |
EBITDA | -46.43M | -600.50% |
Effective tax rate | -1.10% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 143.65M | -13.23% |
Total assets | 258.01M | -10.44% |
Total liabilities | 233.64M | 14.41% |
Total equity | 24.38M | — |
Shares outstanding | 255.56M | — |
Price to book | 9.80 | — |
Return on assets | -45.56% | — |
Return on capital | -218.33% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -48.50M | -4,781.76% |
Cash from operations | -31.95M | 14.30% |
Cash from investing | -358.00K | -100.74% |
Cash from financing | 29.24M | 14,815.82% |
Net change in cash | -3.49M | -129.46% |
Free cash flow | -14.09M | -294.91% |
About
Founded
2008
Website
Employees
449